These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33318010)
1. Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Le W; Su X; Lou X; Li X; Gong X; Wang B; Genco CA; Mueller JP; Rice PA Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318010 [TBL] [Abstract][Full Text] [Related]
2. Gonococcal resistance to zoliflodacin could emerge via transformation from commensal Neisseria species. An in-vitro transformation study. Abdellati S; Laumen JGE; de Block T; De Baetselier I; Van Den Bossche D; Van Dijck C; Manoharan-Basil SS; Kenyon C Sci Rep; 2024 Jan; 14(1):1179. PubMed ID: 38216602 [TBL] [Abstract][Full Text] [Related]
3. High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. Unemo M; Ahlstrand J; Sánchez-Busó L; Day M; Aanensen D; Golparian D; Jacobsson S; Cole MJ; J Antimicrob Chemother; 2021 Apr; 76(5):1221-1228. PubMed ID: 33564854 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). Su XH; Wang BX; Le WJ; Liu YR; Wan C; Li S; Alm RA; Mueller JP; Rice PA Antimicrob Agents Chemother; 2016 Jan; 60(1):621-3. PubMed ID: 26482313 [TBL] [Abstract][Full Text] [Related]
5. Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study. Rubin DH; Mortimer TD; Grad YH Lancet Microbe; 2023 Apr; 4(4):e247-e254. PubMed ID: 36868257 [TBL] [Abstract][Full Text] [Related]
6. Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance. Adamson PC; Lin EY; Ha SM; Klausner JD J Antimicrob Chemother; 2021 Oct; 76(11):2847-2849. PubMed ID: 34324655 [TBL] [Abstract][Full Text] [Related]
7. Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731 [TBL] [Abstract][Full Text] [Related]
8. GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility. Golparian D; Jacobsson S; Sánchez-Busó L; Bazzo ML; Lan PT; Galarza P; Ohnishi M; Unemo M J Antimicrob Chemother; 2022 Dec; 78(1):150-154. PubMed ID: 36308328 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target. Liu J; Jia J; Shi T; Bai Y; Huang Y; Zeng L; Bi H Helicobacter; 2024; 29(2):e13075. PubMed ID: 38627919 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance. Jiang FX; Lan Q; Le WJ; Su XH BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411 [TBL] [Abstract][Full Text] [Related]
12. Interactions between Zoliflodacin and Collins JA; Basarab GS; Chibale K; Osheroff N ACS Infect Dis; 2024 Aug; 10(8):3071-3082. PubMed ID: 39082980 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174 [TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae. Foerster S; Drusano G; Golparian D; Neely M; Piddock LJV; Alirol E; Unemo M J Antimicrob Chemother; 2019 Dec; 74(12):3521-3529. PubMed ID: 31730160 [TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. Zhong J; Le W; Li X; Su X BMC Infect Dis; 2024 Jan; 24(1):104. PubMed ID: 38238655 [TBL] [Abstract][Full Text] [Related]
17. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006. Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988 [TBL] [Abstract][Full Text] [Related]
18. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998. Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group. Ison CA; Martin IM Sex Transm Infect; 1999 Apr; 75(2):107-11. PubMed ID: 10448363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]